Screening compound: InChI=1S/C15H21N5O3/c21-14(11-2-1-3-11)19-8-12(9-19)20-10-13(16-17-20)15(22)18-4-6-23-7-5-18/h10-12H,1-9H2

Screening compound: InChI=1S/C15H21N5O3/c21-14(11-2-1-3-11)19-8-12(9-19)20-10-13(16-17-20)15(22)18-4-6-23-7-5-18/h10-12H,1-9H2
Screening compound: InChI=1S/C15H21N5O3/c21-14(11-2-1-3-11)19-8-12(9-19)20-10-13(16-17-20)15(22)18-4-6-23-7-5-18/h10-12H,1-9H2 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C15H21N5O3/c21-14(11-2-1-3-11)19-8-12(9-19)20-10-13(16-17-20)15(22)18-4-6-23-7-5-18/h10-12H,1-9H2

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S724-0691

Molecular Formula

C15H21N5O3 (C15 H21 N5 O3)

Compound Name

4-[1-(1-cyclobutanecarbonylazetidin-3-yl)-1H-1,2,3-triazole-4-carbonyl]morpholine

IUPAC name

4-[1-(1-cyclobutanecarbonylazetidin-3-yl)-1H-123-triazole-4-carbonyl]morpholine

SMILES

O=C(C1CCC1)N(C1)CC1n1nnc(C(N2CCOCC2)=O)c1

InChI

InChI=1S/C15H21N5O3/c21-14(11-2-1-3-11)19-8-12(9-19)20-10-13(16-17-20)15(22)18-4-6-23-7-5-18/h10-12H,1-9H2

InChI Key

VKAPQJBNCIZXKZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD31984586

InChI=1S/C15H21N5O3/c21-14(11-2-1-3-11)19-8-12(9-19)20-10-13(16-17-20)15(22)18-4-6-23-7-5-18/h10-12H,1-9H2 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Antiviral HBV Library (10007 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Soluble Diversity Library (15920 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with InChI=1S/C15H21N5O3/c21-14(11-2-1-3-11)19-8-12(9-19)20-10-13(16-17-20)15(22)18-4-6-23-7-5-18/h10-12H,1-9H2 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C15H21N5O3/c21-14(11-2-1-3-11)19-8-12(9-19)20-10-13(16-17-20)15(22)18-4-6-23-7-5-18/h10-12H,1-9H2?
Check Price and Availability of InChI=1S/C15H21N5O3/c21-14(11-2-1-3-11)19-8-12(9-19)20-10-13(16-17-20)15(22)18-4-6-23-7-5-18/h10-12H,1-9H2, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C15H21N5O3/c21-14(11-2-1-3-11)19-8-12(9-19)20-10-13(16-17-20)15(22)18-4-6-23-7-5-18/h10-12H,1-9H2 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C15H21N5O3/c21-14(11-2-1-3-11)19-8-12(9-19)20-10-13(16-17-20)15(22)18-4-6-23-7-5-18/h10-12H,1-9H2
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C15H21N5O3/c21-14(11-2-1-3-11)19-8-12(9-19)20-10-13(16-17-20)15(22)18-4-6-23-7-5-18/h10-12H,1-9H2
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C15H21N5O3/c21-14(11-2-1-3-11)19-8-12(9-19)20-10-13(16-17-20)15(22)18-4-6-23-7-5-18/h10-12H,1-9H2 available by request